Julie Spellman Sweet, the Chair and CEO of $ACN, sold 1,843 shares of the company on 02-10-2026 for an estimated $443,969. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.0% of their shares of this class of stock. Following this trade, they now own 18,529 shares of this class of $ACN stock.
$ACN Insider Trading Activity
$ACN insiders have traded $ACN stock on the open market 87 times in the past 6 months. Of those trades, 0 have been purchases and 87 have been sales.
Here’s a breakdown of recent trading of $ACN stock by insiders over the last 6 months:
- JULIE SPELLMAN SWEET (Chair and CEO) has made 0 purchases and 35 sales selling 37,168 shares for an estimated $9,268,631.
- MANISH SHARMA (Chief Strategy & Services Ofcr) has made 0 purchases and 9 sales selling 9,731 shares for an estimated $2,536,952.
- JOHN F WALSH (CEO-The Americas) has made 0 purchases and 9 sales selling 4,000 shares for an estimated $1,105,033.
- MELISSA A BURGUM (Chief Accounting Officer) has made 0 purchases and 6 sales selling 3,603 shares for an estimated $1,012,037.
- JOEL UNRUCH (General Counsel/Corp Secretary) has made 0 purchases and 5 sales selling 2,358 shares for an estimated $655,324.
- RYOJI SEKIDO (Co-CEO Asia Pacific) has made 0 purchases and 3 sales selling 2,500 shares for an estimated $623,674.
- KATHERINE LEE CLIFFORD (Chief Leadership & HR Officer) has made 0 purchases and 13 sales selling 1,468 shares for an estimated $412,092.
- MAURO MACCHI (Chief Executive Officer-EMEA) has made 0 purchases and 2 sales selling 1,000 shares for an estimated $280,000.
- CATHERINE KIERNAN HOGAN (Chief Operating Officer) has made 0 purchases and 5 sales selling 660 shares for an estimated $185,412.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ACN Hedge Fund Activity
We have seen 1,001 institutional investors add shares of $ACN stock to their portfolio, and 1,298 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS added 4,984,930 shares (+41.1%) to their portfolio in Q3 2025, for an estimated $1,229,283,738
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,721,245 shares (+53.6%) to their portfolio in Q3 2025, for an estimated $917,659,017
- PRICE T ROWE ASSOCIATES INC /MD/ removed 3,554,097 shares (-45.9%) from their portfolio in Q3 2025, for an estimated $876,440,320
- CAPITAL RESEARCH GLOBAL INVESTORS removed 2,725,188 shares (-32.4%) from their portfolio in Q3 2025, for an estimated $672,031,360
- AMERIPRISE FINANCIAL INC removed 2,158,227 shares (-42.6%) from their portfolio in Q3 2025, for an estimated $532,218,778
- MORGAN STANLEY removed 1,940,988 shares (-13.9%) from their portfolio in Q3 2025, for an estimated $478,647,640
- CLEARBRIDGE INVESTMENTS, LLC removed 1,906,435 shares (-99.0%) from their portfolio in Q3 2025, for an estimated $470,126,871
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ACN Congressional Stock Trading
Members of Congress have traded $ACN stock 11 times in the past 6 months. Of those trades, 1 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $ACN stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 12/19.
- REPRESENTATIVE KEVIN HERN has traded it 2 times. They made 0 purchases and 2 sales worth up to $300,000 on 10/27, 09/26.
- SENATOR MARKWAYNE MULLIN sold up to $50,000 on 09/24.
- REPRESENTATIVE RICK W. ALLEN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 09/12, 08/19.
- REPRESENTATIVE KELLY MORRISON has traded it 5 times. They made 0 purchases and 5 sales worth up to $145,000 on 08/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ACN Analyst Ratings
Wall Street analysts have issued reports on $ACN in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 12/19/2025
- RBC Capital issued a "Outperform" rating on 12/19/2025
- Mizuho issued a "Outperform" rating on 09/29/2025
- Guggenheim issued a "Buy" rating on 09/26/2025
- TD Cowen issued a "Buy" rating on 09/26/2025
- Evercore ISI Group issued a "Outperform" rating on 09/26/2025
- JP Morgan issued a "Overweight" rating on 09/26/2025
To track analyst ratings and price targets for $ACN, check out Quiver Quantitative's $ACN forecast page.
$ACN Price Targets
Multiple analysts have issued price targets for $ACN recently. We have seen 18 analysts offer price targets for $ACN in the last 6 months, with a median target of $292.5.
Here are some recent targets:
- Jason Kupferberg from Wells Fargo set a target price of $275.0 on 01/14/2026
- Arvind Ramnani from Truist Securities set a target price of $317.0 on 01/06/2026
- Kevin Mcveigh from UBS set a target price of $320.0 on 12/19/2025
- James Friedman from Susquehanna set a target price of $277.0 on 12/19/2025
- Daniel R. Perlin from RBC Capital set a target price of $295.0 on 12/19/2025
- James Faucette from Morgan Stanley set a target price of $320.0 on 12/16/2025
- Bryan Keane from Citigroup set a target price of $266.0 on 10/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
